Creo Financial Statements From 2010 to 2024

Stocks . UK . 
Stock . Creo Medical Group
CREO Stock   16.00  0.13  0.81%   
Creo Medical financial statements provide useful quarterly and yearly information to potential Creo Medical Group investors about the company's current and past financial position, as well as its overall management performance and changes in financial position over time. Historical trend examination of various income statement and balance sheet accounts found on Creo Medical financial statements helps investors assess Creo Medical's valuation, profitability, and current liquidity needs. Key fundamental drivers impacting Creo Medical's valuation are summarized below:
Gross Profit
11.6 M
Profit Margin
(0.74)
Exchange Market
LSE - AIM
Market Capitalization
68 M
Enterprise Value Revenue
2.3386
There are over eighty-seven available fundamental signals for Creo Medical Group, which can be analyzed over time and compared to other ratios. All traders should validate Creo Medical's prevailing fundamentals against the performance from 2010 to 2024 and make sure the trends continue to evolve in the right direction.

Creo Medical Total Revenue

32.34 Million

Check Creo Medical financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Creo Medical's main balance sheet or income statement drivers, such as Depreciation And Amortization of 3.6 M, Interest Expense of 420 K or Selling General Administrative of 42.5 M, as well as many indicators such as . Creo financial statements analysis is a perfect complement when working with Creo Medical Valuation or Volatility modules.
  
This module can also supplement various Creo Medical Technical models . Check out the analysis of Creo Medical Correlation against competitors.

Creo Medical Balance Sheet

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Total Assets80.4 M76.6 M39.9 M
Slightly volatile
Other Current Liabilities2.7 M3.8 M2.7 M
Slightly volatile
Total Current Liabilities5.3 M9.9 M5.5 M
Slightly volatile
Accounts Payable2.6 M2.5 M1.4 M
Slightly volatile
Total Liabilities17.6 M16.8 M8.7 M
Slightly volatile
Property Plant Equipment10.4 M9.9 M3 M
Slightly volatile
Other Liabilities2.9 M2.7 M1.2 M
Slightly volatile
Cash2.9 M3 M17.3 M
Slightly volatile
Net Receivables6.7 M6.4 M2.7 M
Slightly volatile
Total Stockholder Equity31.8 M59.8 M29.2 M
Slightly volatile
Property Plant And Equipment Net9.6 M9.1 M3 M
Slightly volatile
Non Current Assets Total40.6 M38.7 M13.3 M
Slightly volatile
Cash And Short Term Investments26.4 M18.5 M22.5 M
Slightly volatile
Common Stock Total Equity190.7 K181.6 K99 K
Slightly volatile
Common Stock Shares Outstanding328.7 M313 M135.3 M
Slightly volatile
Liabilities And Stockholders Equity55.6 M76.6 M41.1 M
Slightly volatile
Non Current Liabilities Total3.9 M6.9 M2.7 M
Slightly volatile
Other Current Assets3.5 M4.9 M2.7 M
Slightly volatile
Other Stockholder Equity189.9 M180.9 M68 M
Slightly volatile
Property Plant And Equipment Gross18.2 M17.3 M5 M
Slightly volatile
Total Current Assets32.9 M37.9 M26.3 M
Slightly volatile
Common Stock420 K400 K125.4 K
Slightly volatile
Net Tangible Assets29.1 M53.4 M24.6 M
Slightly volatile
Other Assets1.091.1584.3 K
Pretty Stable
Short and Long Term Debt Total5.2 M8.3 M3.2 M
Slightly volatile
Long Term Debt2.4 M4.4 M1.5 M
Slightly volatile
Short and Long Term Debt1.6 M2.5 M1.1 M
Slightly volatile
Intangible Assets10.1 M7.1 M6.8 M
Slightly volatile
Capital Surpluse86.9 M132.6 M63.4 M
Slightly volatile
Capital Lease Obligations1.4 M1.4 M651.7 K
Slightly volatile
Net Invested Capital67.9 M66.7 M46.1 M
Slightly volatile
Net Working Capital29.3 M28 M33.1 M
Slightly volatile
Deferred Long Term Liabilities308 K414 K226.8 K
Slightly volatile
Capital Stock235.7 K400 K177.4 K
Slightly volatile
Non Current Liabilities Other1.9 M2.1 M2.3 M
Slightly volatile

Creo Medical Income Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Depreciation And Amortization3.6 M3.4 M1.1 M
Slightly volatile
Interest Expense420 K400 K96.6 K
Slightly volatile
Selling General Administrative42.5 M40.5 M17.7 M
Slightly volatile
Other Operating Expenses58.4 M55.6 M21.6 M
Slightly volatile
Total Operating Expenses42.1 M40.1 M16.8 M
Slightly volatile
Research Development9.3 M11.9 M6.3 M
Slightly volatile
Interest Income735 K700 K144 K
Slightly volatile
Reconciled Depreciation1.8 M3.4 M1 M
Slightly volatile
Selling And Marketing Expenses13.5 M15.2 M8.8 M
Slightly volatile

Creo Medical Cash Flow Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Stock Based Compensation1.1 M1.2 M791.9 K
Slightly volatile
Begin Period Cash Flow23.8 M13.1 M18.8 M
Slightly volatile
Depreciation3.6 M3.4 M1.1 M
Slightly volatile
Capital Expenditures1.4 M1.2 M1.1 M
Slightly volatile
Total Cash From Financing Activities17.3 M29.8 M14.2 M
Slightly volatile
End Period Cash Flow2.9 M3 M17.3 M
Slightly volatile
Other Cashflows From Investing Activities33.9 K35.6 K49.4 K
Slightly volatile
Change To Liabilities1.1 M2.2 M905.9 K
Slightly volatile
Dividends Paid14 M23 M14 M
Slightly volatile
Issuance Of Capital Stock18.5 M31.7 M38.5 M
Slightly volatile

Creo Fundamental Market Drivers

Cash And Short Term Investments18.5 M

About Creo Medical Financial Statements

Creo Medical shareholders use historical fundamental indicators, such as revenue or net income, to determine how well the company is positioned to perform in the future. Although Creo Medical investors may analyze each financial statement separately, they are all interrelated. The changes in Creo Medical's assets and liabilities, for example, are also reflected in the revenues and expenses on on Creo Medical's income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
Last ReportedProjected for Next Year
Current Deferred Revenue-230 K-241.5 K
Total Revenue30.8 M32.3 M
Cost Of Revenue15.5 M16.3 M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
ESRTEmpire State Realty
CCitigroup
CCitigroup

Additional Tools for Creo Stock Analysis

When running Creo Medical's price analysis, check to measure Creo Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Creo Medical is operating at the current time. Most of Creo Medical's value examination focuses on studying past and present price action to predict the probability of Creo Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Creo Medical's price. Additionally, you may evaluate how the addition of Creo Medical to your portfolios can decrease your overall portfolio volatility.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2024 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY